ADAMTS20

ADAMTS20 is a secreted metalloprotease of the GON-ADAMTS subfamily characterized by 14–15 thrombospondin type-1 repeats (TSRs) and a unique C-terminal GON domain; it cleaves versican in the extracellular matrix and sheds the MT1-MMP ectodomain to regulate cell-surface MMP activity (PMID:12562771, PMID:18454205, PMID:37169079). In mouse skin, ADAMTS20-dependent versican processing is required for melanoblast survival and responsiveness to soluble Kit ligand, and loss of Adamts20 causes a dramatic increase in melanoblast apoptosis and white spotting (PMID:18454205). ADAMTS20 activity depends on B3GLCT-mediated O-glucosylation of its TSRs; loss of this modification selectively abolishes ADAMTS20 function in vivo, producing white spotting and cleft palate (PMID:31600785).

1. 2003 High

   Establishing that ADAMTS20 is a catalytically active secreted metalloprotease in a distinct GON-ADAMTS subfamily resolved the gene's basic enzymatic identity and domain organization, and the parallel demonstration that its closest paralog ADAMTS9 cleaves versican predicted a shared substrate specificity.

   Evidence cDNA cloning, domain analysis, in vitro peptide hydrolysis for ADAMTS20; COS-1 cell transfection, mutagenesis, and amino acid sequencing for ADAMTS9 versicanase activity

   PMID:12514189 PMID:12562771

   Open questions at the time

   • Direct demonstration of versican cleavage by ADAMTS20 itself was not yet shown
   • No physiological substrate identified for ADAMTS20 in vivo
   • Synthetic peptide assay does not establish physiological relevance of catalytic activity
2. 2008 High

   Demonstrating that ADAMTS20 cleaves versican both in vitro and in vivo, and that this activity is required for melanoblast survival and Kit-ligand responsiveness, established the first physiological role for ADAMTS20 and linked ECM remodeling to melanocyte biology.

   Evidence Dct-LacZ melanoblast tracking, TUNEL assays, skin explant cultures, in vitro versican cleavage, in vivo versican immunostaining, and genetic compound-mutant analysis with Kit/KitL in belted mice

   PMID:18454205

   Open questions at the time

   • Mechanism by which versican cleavage promotes Kit signaling was not defined
   • Whether ADAMTS20 has additional ECM substrates beyond versican remained unknown
   • Role of ADAMTS20 in tissues other than skin was not addressed
3. 2019 High

   Showing that B3GLCT-mediated O-glucosylation of TSRs is required for ADAMTS20 function — more so than for ADAMTS9 — established a post-translational regulatory mechanism that differentially controls paralog activity in vivo.

   Evidence Mouse B3glct knockout models, genetic rescue experiments, biochemical analysis of ADAMTS20 secretion and processing, phenotypic comparison (white spotting, cleft palate)

   PMID:31600785

   Open questions at the time

   • Whether O-glucosylation affects ADAMTS20 secretion, folding, or substrate engagement was not resolved
   • Structural basis for the selective dependence of ADAMTS20 versus ADAMTS9 on B3GLCT was not determined
4. 2023 High

   Identification of MT1-MMP as an ADAMTS9/20 substrate by unbiased terminomics, with cleavage at a specific hinge-region bond dependent on O-glycosylation, expanded ADAMTS20's substrate repertoire to include regulation of cell-surface metalloproteinase activity and downstream pro-MMP2 activation.

   Evidence TAILS terminomics in clonal ADAMTS9 KO / ADAMTS20-null RPE-1 cells, reexpression rescue, Western blot fragment detection, pro-MMP2 activation assay, MT1-MMP knockdown epistasis

   PMID:37169079

   Open questions at the time

   • Relative contributions of ADAMTS9 versus ADAMTS20 to MT1-MMP shedding in vivo remain undefined
   • Whether MT1-MMP shedding underlies any ADAMTS20-dependent developmental phenotype (e.g., melanoblast survival) is untested
   • Full in vivo substrate repertoire of ADAMTS20 beyond versican and MT1-MMP is unknown

• The complete in vivo substrate repertoire of ADAMTS20, the structural basis for its selective dependence on TSR O-glucosylation, and the mechanism linking versican cleavage to Kit signaling remain unresolved.
• No structural model of ADAMTS20 or its substrate complexes exists
• Mechanistic link between versican processing and Kit-ligand signaling pathway has not been defined
• Roles of ADAMTS20 in non-melanocyte lineages and non-skin tissues are poorly characterized